ArticleCurrent oncology (Toronto, Ont.)2026

Real-World Toxicities and Outcomes of Pembrolizumab in Early-Stage Triple-Negative Breast Cancer.

Emmanuel Joran Boujeke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.